Abstract
The intravenous and oral dose-dependent pharmacokinetics of hydralazine and the effect of concurrent administration of food with hydralazine in dogs were evaluated for comparison with published human data. Four dogs were given intravenous and oral doses of hydralazine at 0.25, 1.0, 2.5, and 4.0 mg/kg. In addition, the oral 2.5 mg/kg dose was given with a meal. Blood samples were collected at appropriate intervals and analyzed for hydralazine. Pharmacokinetic analysis showed that AUCoral/ dose (5552 to 13218 mg-min/ml) and F (0.36 to 0.77) increased significantly with dose, indicating saturation of first-pass metabolism, as is seen in humans. Total-body clearance (70 ml/min/kg) and steady-state volume of distribution (9 L/kg) were similar to human values. The bioavailability of hydralazine in the dog was decreased by 63% when the dose was given with a meal, which is comparable to some human data. It was concluded that the dog may be a useful model in which to study mechanisms of the hydralazine-food interaction.
Similar content being viewed by others
REFERENCES
T. M. Ludden, J. L. McNay, Jr., A. M. M. Shepherd, and M. S. Lin. Clin. Pharmacokin. 7:185–205 (1982).
A. M. M. Shepherd, J. L. McNay, Jr., T.. M. Ludden, M. S. Lin, and G. E. Musgrave. Hypertension 3:580–585 (1981).
P. A. Reece, I. Cozamanis, and R. Zacest. Clin. Pharmacol. Ther. 28:769–778 (1980).
A. Melander, K. Danielson, A. Hanson, B. Rudell, B. Schersten, T. Thulin, and E. Wahlin. Clin. Pharmacol. Ther. 22:104–107 (1977).
A. M. M. Shepherd, N. A. Irvine, and T. M. Ludden. Clin. Pharmacol. Ther. 36:14–18 (1984).
A. M. M. Shepherd, S. H. Jackson, M. J. Jamieson, P. Flanagan, T. M. Ludden, and J. Woodworth. Clin. Pharmacol. Ther. 41:174, PPH-5 (1987).
B. Heinzow, H. Corbett, S. Constantinides, R. Bourne, and A. J. McLean. J. Pharmacol. Exp. Ther. 229:509–514 (1984).
H. Corbett, C. M. Cahill, B. Heinzow, P. M. Harrison, A. J. Byrne, and A. J. McLean. J. Pharmacol. Exp. Ther. 239:517–521 (1986).
J. M. Lesser, Z. H. Israili, D. C. Davis, and P. G. Dayton. Drug Metab. Disp. 2:351–360 (1974).
M. D. Kittleson, L. E. Johnson, and N. B. Oliver. J. Am. Vet. Med. Assoc. 187:258–261 (1985).
R. L. Hamlin and M. D. Kittleson. J. Am. Vet. Med. Assoc. 180:1327–1329 (1982).
M. D. Kittleson, G. E. Eyster, N. B. Olivier, and L. K. Anderson. J. Am. Vet. Med. Assoc. 182:1205–1209 (1983).
T. Saretok, O. Almersjo, B. Biber, B. Gustavsson, and P. O. Hasselgren. Acta Chir. Scand. 150:1–4 (1984).
H. B. Hucker. In E. R. Garret and J. L. Hirtz (eds.), Drug Fate and Metaolism, Vol. 4. Marcel Dekker, New York, 1983, pp. 335–385.
T. M. Ludden, K. S. Rotenburg, L. K. Ludden, A. M. M. Shepherd, and J. R. Woodworth. J. Pharm. Sci. 77:1026–1032 (1988).
A. M. M. Shepherd, N. A. Irvine, T. M. Ludden, M.-S. Lin, and J. L. McNay. Clin. Pharmacol. Ther. 36:595–600 (1984).
H. A. Semple, Y. K. Tarn, S. Tin, and R. T. Coutts. Pharm. Res. 5:383–386 (1988).
M. L. Rocci, Jr. Comp. Prog. Biomed. 16:203–216 (1983).
M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, 1982.
T. M. Ludden, A. M. M. Shepherd, J. L. McNay, and M.-S. Lin. Clin. Pharmacol. Ther. 28:736–742 (1980).
A. M. M. Shepherd, T. M. Ludden, J. L. McNay, and M.-S. Lin. Clin. Pharmacol. Ther. 28:804–811 (1980).
G. M. Rubin and T. N. Tozer. J. Pharmacokin. Biopharm. 12:437–450 (1984).
G. M. Rubin, J. A. Waschek, S. M. Pond, D. J. Effeney, and T. N. Tozer. J. Pharmacokin. Biopharm. 15:615–631 (1987).
S. D. Hall, C. B. McAllister, and G. R. Wilkinson. J Pharmacokin. Biopharm. 16:263–278 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Semple, H.A., Tam, Y.K. & Coutts, R.T. Hydralazine Pharmacokinetics and Interaction with Food: An Evaluation of the Dog as an Animal Model. Pharm Res 7, 274–279 (1990). https://doi.org/10.1023/A:1015830330231
Issue Date:
DOI: https://doi.org/10.1023/A:1015830330231